FBR Share Price Increased After Completion Of Its Hadrian X Construction Robot

FBR

On 28 September 2018, FBR Limited (ASX: FBR) announced that the fully operational build of its Hadrian X construction robot is completed and after the release of this news FBR’s share prices increased by 12.121% as on 28 September 2018. The company will now start the Factory Acceptance Testing in which Hadrian X will build structures in different configurations within a controlled environment. The DST technology of the company is functioning as intended with the Hadrian X and the company is focused on completing the first build of the house with the world first fully automated, end to end brick laying robot. It is expected that in the second half of calendar year 2018, the company will finish its Built1 which is the first build of a 3-bedroom, 2-bathroom structure by the Hadrian X.   

In the FY2018, the company’s revenue from ordinary activities increased by 207% to $535,486 compared to previous year. Company’s loss from operating activities after tax increased by 277% to $7.12 million primarily due to increase in procurement and staff costs as the Hadrian X programme is getting closer to the demonstration stage. The company maintained a strong financial position at the end of FY 2018 with $21.96 million in cash and $8.16 million in receivables. The net tangible assets per share increased from 1.19 cents in FY 2017 to 2.72 cents in FY 2018. In June 2018, the company entered into a strategic collaboration agreement with GP Vivienda to evaluate pilot testing programmes for Hadrian X in Mexico and to discuss the opportunities for future uses of company’s core Dynamic Stabilization Technology. The company is planning to continue the Hadrian X programme towards commercialization in FY 2019 and it is also planning to invest in the company’s intellectual property portfolio and its employees. Focus of the company during FY 2019 will be the demonstration of Hadrian X construction robot and further refinements to its operating performances and complete its extensive Testing Process.

In the last six months, the share price of the company increased by 10% from $0.150 to $0.165 as on 27 September 2018. FBR’s share traded at $0.185 with a market capitalization of $175.21 million as on 28 September 2018.

Dividend Stocks To Buy

The Income available from dividends remains attractive for many investors.

We take a look at the best yields on the market and assess what they say about a company’s prospect.

Sponsored ad by Kalkine

One Thing is certain, though, Australia interest rates are still low, making income difficult to come by and keeping the focus for many investors on high yielding stocks. Kalkine’s team of analysts bought you handpicked report for “Top 25 Dividend Stocks For 2018.”

ASX-relevant Special Reports are published year-round to provide a detailed analysis into an investing opportunity or a potential risk to your portfolio.

Click here to get your free report.


Disclaimer

The advice given by Kalkine Pty Ltd and provided on this website is general information only and it does not take into account your investment objectives, financial situation or needs. You should therefore consider whether the advice is appropriate to your investment objectives, financial situation and needs before acting upon it. You should seek advice from a financial adviser, stockbroker or other professional (including taxation and legal advice) as necessary before acting on any advice. Not all investments are appropriate for all people. Kalkinemedia.com and associated websites are published by Kalkine Pty Ltd ABN 34 154 808 312 (Australian Financial Services License Number 425376). website), employees and/or associates of Kalkine Pty Ltd do not hold positions in any of the stocks covered on the website. These stocks can change any time and readers of the reports should not consider these stocks as advice or recommendations.

Join Our Discussion

Start discussion with value Investors for ASX Stock Market Investment and Opinion.


6 Cannabis Stocks under Investor’s Limelight…

Cannabis companies that sell both medicinal weed and recreational pot. Marijuana stocks to look at. Marijuana mergers and acquisitions. Dispensary data analytics. Upcoming marijuana IPO’s Those phrases have become increasingly common as marijuana legalization spreads.

Global spending on legal cannabis is expected to grow 230% to $32 billion in 2020 as compared to $9.5 in 2017, according to Arcview Market Research and BDS Analytics. As of June 29, 2018 the United States Marijuana Index, despite a lot of uncertainty around regulations, has over the past 1 year gained 71.49%, as compared to about 12% gain seen by the S&P 500.

Click here for your FREE Report

LEAVE A REPLY

Please enter your comment!
Please enter your name here